Skip to main content

Table 1 Characteristics of the patients*

From: Salvage thoracic surgery in patients with lung cancer: potential indications and benefits

 

Total (n = 30)

Group 1 (n = 22)

Group 2 (n = 3)

Group 3 (n = 5)

Age (years, ± SD)

63 ± 7

63 ± 8

64 ± 3

62 ± 8

Male/Female

26/4

21/1

3/0

2/3

Presence of comorbidity (n, %)

18 (60%)

11 (50%)

2 (67%)

5 (100%)

Operation type (n)

    

 Lobectomy

14

11

0

3

 Greater resection

11a

8b

2c

1d

 Segmentectomy

5

3

1

1

Extended resection (n, %)**

16 (53%)

13 (59%)

1 (33%)

2 (40%)

Length of hospital stay (mean days ± SD)

11 ± 4

10 ± 4

14 ± 2

13 ± 9

Mortality (n, %)

1 (3%)

0

0

1 (20%)

Morbidity (n, %)

21 (70%)

14 (64%)

3 (100%)

4 (80%)

Overall survival (mean months ± SD)

19 ± 13

22 ± 13

13 ± 5

6 ± 2

Relapse-free survival (mean months ± SD)

14 ± 12

16 ± 13

9 ± 4

6 ± 2

  1. aPneumonectomy, 8; bilobectomy, 2; lobectomy + segmentectomy, 1
  2. bPneumonectomy, 6; bilobectomy, 1 lobectomy +segmentectomy, 1
  3. cPneumonectomy, 1; bilobectomy, 1
  4. dPneumonectomy, 1
  5. SD: Standart Deviation
  6. *P > 0.05 for all parameters
  7. **Including sleeve resection (bronchial or arterial), chest wall resection, pericardial resection and reconstruction, right atrial resection, and diaphragmatic resection and reconstruction